Premenstrual syndrome and quality of life of woman. Effectiveness of herbal drugs

В. Н. Прилепская, Э. Р. Довлетханова

Abstract


The premenstrual syndrome (PMS) is a pathological symptom that significantly reduces the quality of a woman’s life. The etiology and pathogenesis to date have not been sufficiently studied, but the diagnosis, treatment and prevention that are to be complied with have been identified. The treatment of the PMS should be differentiated, taking into account the overall and reproductive health of the woman, the concomitant diseases, the degree of severity of ICP, the portability of therapy, etc.


Keywords


рremenstrual syndrome; PMS; quality of life; virgin bush; Vitex Agnus-castus; Mastodynon; Cyclodinon

References


Prilepskaya, V.N., Ledina, A.V., Tagiyeva, A.V., Revazova, F.S. “Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome.” Maturitas 55 Suppl. 1 (2006): 55–63.

Aganezova, N.V. “Premenstrual syndrome: biological and psychosocial predictors of pathogenesis, clinic, rationale for complex therapy.” Thesis for MD degree. St. Petersburg (2011): 372 p.

Ledina, A.V. “Premenstrual syndrome: epidemiology, clinical picture, diagnosis and treatment.” Thesis abstract for MD degree. Moscow (2014).

Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome. Green-top Guideline No. 48. BJOG (2016). DOI: 10.1111/1471-0528.14260

Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta MedIran 50 (2012): 101–6.

Prilepskaya, V.N., Mezhevitinova, E.A., Sasunova, R.A., et al. “Results of clinical use of a drug containing drospirenone in women with severe premenstrual syndrome.” Obstetrics and gynecology 2 (2012): 81–5.

Rafieian-Kopaei, M., Movahedi, M. “Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus.” Electronic Physician 9.1 (2017): 3685–9.

Sarrafchi, A., Bahmani, M., Shirzad, H., Rafieian-Kopaei, M. “Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants.” Curr Pharm Des 22.2 (2016): 238–46.

Miraj, S., Rafieian-Kopaei, M., Kiani, S. “Melissa officinalis L: A Review Study With an Antioxidant Prospective.” J Evid Based Complementary Altern Med, 2016. DOI: 10.1177/2156587216663433

Baharvand-Ahmadi, B., Bahmani, M., Tajeddini, P., et al. “An ethnobotanical study of medicinal plants administered for the treatment of hypertension.” J Renal Inj Prev 5.3 (2016): 123–8. DOI: 10.15171/jrip.2016.26

Rouhi-Boroujeni, H., Gharipour, M., Mohammadizadeh, F., et al. “Systematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist.” Acta Biomed 86.2 (2015): 130–6.

Khalilzadeh, E., Vafaei Saiah, G., Hasannejad, H., et al. “Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil.” Avicenna J Phytomed 5.3 (2015): 218–30.

He, Z., Chen, R., Zhou, Y., et al. “Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multicenter placebo controlled study in China.” Maturitas 63.1 (2009): 99–103. DOI: 10.1016/j.maturitas.2009.01.006

Jang, S.H., Kim, D.I., Choi, M.S. “Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review.” BMC Complement Altern Med 14 (2014): 11. DOI: 10.1186/1472-6882-14-11

Weisz, G., Knaapen, L. “Diagnosing and treating premenstrual syndrome in five western nations.” Soc Sci Med 68.8 (2009): 1498–505. DOI: 10.1016/j.socscimed.2009.01.036

Atmaca, M., Kumru, S., Tezcan, E. “Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.” Hum Psychopharmacol 18.3 (2003): 191–5. DOI: 10.1002/hup.470

Ma, L., Lin, S., Chen, R., et al. “Evaluating therapeutic effect in symptoms of moderate - to - severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.” Aust N Z J Obstet Gynaecol 50.2 (2010): 189–93. DOI: 10.1111/j.1479-828X.2010.01137.x

Kelderhouse, K., Taylor, J.S. “A review of treatment and management modalities for premenstrual dysphoric disorder.” Nurs Womens Health 17.4 (2013): 294–305. DOI: 10.1111/1751-486X.12048

Dietz, B.M., et al. “Botanicals and Their Bioactive Phytochemicals for Women’s Health.” Pharmacol Rev 68.4 (2016): 1026–73.

Rafieian-Kopaei, M., Saki, K., Bahmani, M., et al. “Listeriosis Phytotherapy: A Review Study on the Effectiveness of Iranian Medicinal Plants in Treatment of Listeriosis.” J Evid Based Complementary Altern Med (2015). DOI: 10.1177/2156587215621460

van Die, M.D., Burger, H.G., Teede, H.J., Bone, K.M. “Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials.” Women’s Health. Planta Med 79.07 (2013): 562–75.

Bahmani, M., Sarrafchi, A., Shirzad, H., Rafieian-Kopaei, M. “Autism: Pathophysiology and Promising Herbal Remedies.” Curr Pharm Des 22.3 (2016): 277–85. DOI: 10.2174/1381612822666151112151529

Ambrosini, A., Di Lorenzo, C., Coppola, G., Pierelli, F. “Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation.” Acta Neurol Psychiatr Belg 113.1 (2013): 25–9. DOI: 10.1007/s13760-012-0111-4

Webster, D.E., He, Y., Chen, S.N., et al. “Opioidergic mechanisms underlying the actions of Vitex agnus-castus L.” Biochem pharmacol 81.1 (2011): 170–7. DOI: 10.1016/j.bcp.2010.09.013

van Die, M.D., Bone, K.M., Burger, H.G., et al. “Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis.” J Altern Complement Med 15.9 (2009): 1045–8. DOI: 10.1089/acm.2008.0539

Royal College of Obstetricians and Gynaecologists. NAPS Guidelines on Guidelines on Premenstrual Syndrom, 01.12.2016.

Marjoribanks, J., Brown, J., O’Brien, P.M., Wyatt, K. “Selective serotonin reuptake inhibitors for premenstrual syndrome.” Cochrane Database Syst Rev 6 (2013): CD001396. DOI: 10.1002/14651858.CD001396.pub3

Upchurch, D.M., Chyu, L., Greendale, G.A., et al. “Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002.” J Women’s Health (Larchmt) 16 (2007): 102–13.

Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta Med Iran 50.2 (2012): 101–6.

Ledina, A.V., Prilepskaya, V.N. “Drospirenone-Contraceptive: Therapeutic and Prophylactic Aspects of Use.” Gynecology 17.1 (2015): 25–9.

Lauritzen, C., Reuter, H.D., Repges, R., et al. “Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, doubleblind study versus pyridoxine.” Phytomedicine 4.3 (1997): 183–9. DOI: 10.1016/S0944-7113(97)80066-9

Andrade, C. “Premenstrual dysphoric disorder: General overview, treatment strategies, and focus on sertraline for symptom-onset dosing.” Indian J Psychiatry 58.3 (2016): 329–31. DOI: 10.4103/0019-5545.192014

Ryu, A., Kim, T.H. “Premenstrual syndrome: A mini review.” Maturitas 82.4 (2015): 436–40. DOI: 10.1016/j.maturitas.2015.08.010


GOST Style Citations


1. Prilepskaya, V.N., Ledina, A.V., Tagiyeva, A.V., Revazova, F.S. “Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome.” Maturitas 55 Suppl. 1 (2006): 55–63.

2. Аганезова, Н.В. Предменструальный синдром: биологические и психосоциальные предикторы патогенеза, клиника, обоснование комплексной терапии / Н.В. Аганезова. Диссертация на соискание ученой степени доктора мед. наук. – Санкт-Петербург, 2011. – 372 с.

3. Ледина, А.В. Предменструальный синдром: эпидемиология, клиника, диагностика и лечение / А.В. Ледина. Автореферат диссертации на соискание ученой степени доктора мед. наук. – Москва, 2014.

4. Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome. Green-top Guideline No. 48. BJOG (2016). DOI: 10.1111/1471-0528.14260

5. Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta MedIran 50 (2012): 101–6.

6. Прилепская, В.Н. Результаты клинического применения препарата, содержащего дроспиренон, у женщин с тяжелой формой предменструального синдрома / В.Н. Прилепская, Е.А. Межевитинова, Р.А. Сасунова и др. // Акушерство и гинекология. – 2012. – №2. – С. 81–85.

7. Rafieian-Kopaei, M., Movahedi, M. “Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus.” Electronic Physician 9.1 (2017): 3685–9.

8. Sarrafchi, A., Bahmani, M., Shirzad, H., Rafieian-Kopaei, M. “Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants.” Curr Pharm Des 22.2 (2016): 238–46.

9. Miraj, S., Rafieian-Kopaei, M., Kiani, S. “Melissa officinalis L: A Review Study With an Antioxidant Prospective.” J Evid Based Complementary Altern Med, 2016. DOI: 10.1177/2156587216663433

10. Baharvand-Ahmadi, B., Bahmani, M., Tajeddini, P., et al. “An ethnobotanical study of medicinal plants administered for the treatment of hypertension.” J Renal Inj Prev 5.3 (2016): 123–8. DOI: 10.15171/jrip.2016.26

11. Rouhi-Boroujeni, H., Gharipour, M., Mohammadizadeh, F., et al. “Systematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist.” Acta Biomed 86.2 (2015): 130–6.

12. Khalilzadeh, E., Vafaei Saiah, G., Hasannejad, H., et al. “Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil.” Avicenna J Phytomed 5.3 (2015): 218–30.

13. He, Z., Chen, R., Zhou, Y., et al. “Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multicenter placebo controlled study in China.” Maturitas 63.1 (2009): 99–103. DOI: 10.1016/j.maturitas.2009.01.006

14. Jang, S.H., Kim, D.I., Choi, M.S. “Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review.” BMC Complement Altern Med 14 (2014): 11. DOI: 10.1186/1472-6882-14-11

15. Weisz, G., Knaapen, L. “Diagnosing and treating premenstrual syndrome in five western nations.” Soc Sci Med 68.8 (2009): 1498–505. DOI: 10.1016/j.socscimed.2009.01.036

16. Atmaca, M., Kumru, S., Tezcan, E. “Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.” Hum Psychopharmacol 18.3 (2003): 191–5. DOI: 10.1002/hup.470

17. Ma, L., Lin, S., Chen, R., et al. “Evaluating therapeutic effect in symptoms of moderate - to - severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.” Aust N Z J Obstet Gynaecol 50.2 (2010): 189–93. DOI: 10.1111/j.1479-828X.2010.01137.x

18. Kelderhouse, K., Taylor, J.S. “A review of treatment and management modalities for premenstrual dysphoric disorder.” Nurs Womens Health 17.4 (2013): 294–305. DOI: 10.1111/1751-486X.12048

19. Dietz, B.M., et al. “Botanicals and Their Bioactive Phytochemicals for Women’s Health.” Pharmacol Rev 68.4 (2016): 1026–73.

20. Rafieian-Kopaei, M., Saki, K., Bahmani, M., et al. “Listeriosis Phytotherapy: A Review Study on the Effectiveness of Iranian Medicinal Plants in Treatment of Listeriosis.” J Evid Based Complementary Altern Med (2015). DOI: 10.1177/2156587215621460

21. van Die, M.D., Burger, H.G., Teede, H.J., Bone, K.M. “Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials.” Women’s Health. Planta Med 79.07 (2013): 562–75.

22. Bahmani, M., Sarrafchi, A., Shirzad, H., Rafieian-Kopaei, M. “Autism: Pathophysiology and Promising Herbal Remedies.” Curr Pharm Des 22.3 (2016): 277–85. DOI: 10.2174/1381612822666151112151529

23. Ambrosini, A., Di Lorenzo, C., Coppola, G., Pierelli, F. “Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation.” Acta Neurol Psychiatr Belg 113.1 (2013): 25–9. DOI: 10.1007/s13760-012-0111-4

24. Webster, D.E., He, Y., Chen, S.N., et al. “Opioidergic mechanisms underlying the actions of Vitex agnus-castus L.” Biochem pharmacol 81.1 (2011): 170–7. DOI: 10.1016/j.bcp.2010.09.013

25. van Die, M.D., Bone, K.M., Burger, H.G., et al. “Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis.” J Altern Complement Med 15.9 (2009): 1045–8. DOI: 10.1089/acm.2008.0539

26. Royal College of Obstetricians and Gynaecologists. NAPS Guidelines on Guidelines on Premenstrual Syndrom, 01.12.2016.

27. Marjoribanks, J., Brown, J., O’Brien, P.M., Wyatt, K. “Selective serotonin reuptake inhibitors for premenstrual syndrome.” Cochrane Database Syst Rev 6 (2013): CD001396. DOI: 10.1002/14651858.CD001396.pub3

28. Upchurch, D.M., Chyu, L., Greendale, G.A., et al. “Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002.” J Women’s Health (Larchmt) 16 (2007): 102–13.

29. Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta Med Iran 50.2 (2012): 101–6.

30. Ледина, А.В. Дроспиренон-содержащий контрацептив: лечебные и профилактические аспекты применения / А.В. Ледина, В.Н. Прилепская // Гинекология. – 2015. – №17(1). – С. 25–29.

31. Lauritzen, C., Reuter, H.D., Repges, R., et al. “Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, doubleblind study versus pyridoxine.” Phytomedicine 4.3 (1997): 183–9. DOI: 10.1016/S0944-7113(97)80066-9

32. Andrade, C. “Premenstrual dysphoric disorder: General overview, treatment strategies, and focus on sertraline for symptom-onset dosing.” Indian J Psychiatry 58.3 (2016): 329–31. DOI: 10.4103/0019-5545.192014

33. Ryu, A., Kim, T.H. “Premenstrual syndrome: A mini review.” Maturitas 82.4 (2015): 436–40. DOI: 10.1016/j.maturitas.2015.08.010





DOI: https://doi.org/10.18370/2309-4117.2018.39.76-80

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)